EUVIMEDEUVIMED entdecken
Crossref

DBT more efficacious than SSRI in reducing suicidality in borderline personality disorder

The Brown University Psychopharmacology Update · 2026-03 · 37 (3) · 3-4

DOI: 10.1002/pu.31417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Brown University Psychopharmacology Update, online erschienen am 23.02.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Six months of dialectical behavior therapy (DBT) was more efficacious than a 6‐month course of treatment with a selective serotonin reuptake inhibitor (SSRI) antidepressant in reducing suicide‐related events in patients with borderline personality disorder, a randomized trial has found. However, SSRI treatment was more efficacious than DBT in reducing diagnoses of major depressive disorder at 6 months.

Zitieren

APA

(2026). DBT more efficacious than SSRI in reducing suicidality in borderline personality disorder. The Brown University Psychopharmacology Update, 37(3), 3-4. https://doi.org/10.1002/pu.31417

Vancouver

DBT more efficacious than SSRI in reducing suicidality in borderline personality disorder. The Brown University Psychopharmacology Update. 2026;37(3):3-4. doi:10.1002/pu.31417

BibTeX
@article{euvimed2026,
  title = {DBT more efficacious than SSRI in reducing suicidality in borderline personality disorder},
  journal = {The Brown University Psychopharmacology Update},
  year = {2026},
  volume = {37},
  number = {3},
  pages = {3--4},
  doi = {10.1002/pu.31417}
}
Kostenlos starten →